| UHC Commercial Medical & Drug | Xiaflex® (Collagenase Clostridium Histolyticum) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| Ambetter Health Alabama Clinical | Concert Genetic Testing: Multisystem Genetic Conditions (V2.2025) | 2026-01-01 |
| Ambetter Health Georgia Clinical | Concert Genetic Testing: Multisystem Genetic Conditions | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Experimental Technologies | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Fertility Preservation | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Gastric Electrical Stimulation | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Home Births | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Implantable Hypoglossal Nerve Stimulation for Obstructive | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Nonmyeloablative Allogeneic Stem Cell Transplants | 2026-01-01 |
| Meridian Illinois Medicaid Clinical | Allogeneic Hematopoietic Progenitor Cell Therapy | 2026-01-01 |